Trial Profile
The Effect of Usual Dose Rosuvastatin Plue Ezetimibe Versus High-dose Rosuvastatin on Coronary Atherosclerotic Plaque: A Randomized Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2023
Price :
$35
*
At a glance
- Drugs Ezetimibe/rosuvastatin (Primary) ; Rosuvastatin
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms Rosuzet-IVUS
- 24 Nov 2023 Planned primary completion date changed from 31 Dec 2022 to 31 Dec 2023.
- 10 Nov 2021 Planned End Date changed from 31 Dec 2023 to 31 Dec 2024.
- 10 Nov 2021 Planned primary completion date changed from 31 Dec 2021 to 31 Dec 2022.